Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Virologic Failure”

Showing 7 of 0 results

Not applicableStudy completedNCT07815418
What this trial is testing

The Relationship Between Novel Virological Indicators and Treatment With Different Nucleotide Analogues and the Prognosis of HBV-ACLF Patients

Who this might be right for
Acute-on-Chronic Liver Failure (ACLF)hepatitisBTreatment
Tongji Hospital 235
Testing effectiveness (Phase 2)UnknownNCT02025868
What this trial is testing

Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 201
Large-scale testing (Phase 3)Study completedNCT00028301
What this trial is testing

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Large-scale testing (Phase 3)UnknownNCT04429152
What this trial is testing

ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavirenz-based Antiretroviral Therapy With NNRTI Resistance

Who this might be right for
HIV-1-infection
Professor Francois Venter 25
Testing effectiveness (Phase 2)Study completedNCT00102206
What this trial is testing

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Post-approval studies (Phase 4)Study completedNCT00038506
What this trial is testing

Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure

Who this might be right for
HIV Infection
ViiV Healthcare 100
Post-approval studies (Phase 4)Study completedNCT00931463
What this trial is testing

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

Who this might be right for
HIV Infections
Kirby Institute 558

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation